ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, it advances clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. ICON has applied its operational and services expertise to develop our third-generation mobile patient engagement and data capture platform, configured to conduct the decentralized clinical trials of today and the future.

The ICON Digital Platform (IDP) captures, curates and consumes data for decentralized clinical trials. The Platform is built on a scalable cloud-first framework, hosted on Microsoft Azure. Our platform is modular, fully configurable, and designed specifically to reduce clinical trial burden for patients and sites and increase engagement through one unified platform.

Currently offering the following features:

• Mobile App: Patient study engagement application, with offline capabilities available for IOS and Android.
• eConsent: Easy to use consent signing workflow in both mobile/remote (eSignature) and on-site (print-to-sign) settings.
• eCOA: Quick configuration and easy to build, eDiary, COA and Patient Reported Outcomes

• Televisit: Schedule and perform virtual one-on-one patient visits securely via an internet connection on a smart phone, tablet or computer
• In-Home Services: Digital, end-to-end in-home solution offering visit management and notifications to support sites, nurses and study managers.
• Tokenization: Tokenise patients for inclusion/integration of real world data as evidence in clinical trial reporting/analytics.
• Reports and dashboards: Direct user access to organised task management and meaningful, actionable summary data, through a landing page.

We provide support for all countries and languages enabled on the platform.

Benefits of IDP bring to your study: Speed, scalability and quality data